In Peutz-Jeghers and BRCA2 carriers, when does pancreatic cancer surveillance typically begin?

In Peutz-Jeghers and BRCA2 carriers, when does pancreatic cancer surveillance typically begin?

• A. Annual pancreatic imaging starting in young adulthood.
• B. Surveillance begins in childhood before age 10.
• C. Surveillance begins at age 60 only if symptoms arise.
• D. There is no specific pancreatic cancer surveillance for these groups.

Answer: (A)

In people with high hereditary risk, pancreatic cancer screening is started in young adulthood because their lifetime risk is significantly elevated and cancers can develop earlier. For Peutz-Jeghers and BRCA2 carriers, annual pancreatic imaging—typically MRI with MRCP or endoscopic ultrasound—is recommended already in the early adult years, not in childhood and not only at age 60. Regular imaging aims to detect lesions before symptoms appear, allowing earlier management. Starting surveillance later (in childhood or at age 60 only if symptoms) would miss many cancers and isn’t consistent with how these risks are managed. There is indeed a rationale for ongoing surveillance in these high-risk groups, hence the choice of starting in young adulthood with annual imaging.

In people with high hereditary risk, pancreatic cancer screening is started in young adulthood because their lifetime risk is significantly elevated and cancers can develop earlier. For Peutz-Jeghers and BRCA2 carriers, annual pancreatic imaging—typically MRI with MRCP or endoscopic ultrasound—is recommended already in the early adult years, not in childhood and not only at age 60. Regular imaging aims to detect lesions before symptoms appear, allowing earlier management.

Starting surveillance later (in childhood or at age 60 only if symptoms) would miss many cancers and isn’t consistent with how these risks are managed. There is indeed a rationale for ongoing surveillance in these high-risk groups, hence the choice of starting in young adulthood with annual imaging.